MaterniT21™ PLUS Test for Fetal Aneuploidies
Click here to learn more about the MaterniT21 PLUS laboratory- developed test (LDT) for fetal aneuploidies. Developed and validated by Sequenom CMM, the test analyzes the relative amount of 21, 18, 13, X and Y chromosomal material in circulating cell-free DNA from a maternal blood sample. The test detects fetal aneuploidies for chromosomes 21, 18, 13 in singletons, twins and higher order multiple pregnancies.1,2,3 The MaterniT21 PLUS test also makes a determination for chromosomes X and Y.4 Sex chromosomal aneuploidies are not reported in multiple pregnancies.
Heredi-T™ Cystic Fibrosis Carrier Screen Test
Click here to learn more about an impactful new CF carrier screen that detects a phenotypically-confirmed (disease-causing) panel selected from the John Hopkins CFTR2 database.
SensiGene® Fetal RHD Genotyping Test
Click here to learn more about SensiGene® Fetal RHD Genotyping test, a noninvasive LDT that can directly determine fetal RHD status. In RhD negative sensitized patients it may avoid invasive testing by CVS or genetic amniocentesis.
RetnaGene™ AMD Test for Age-Related Macular Degeneration
Click here to learn more about RetnaGene™ AMD, a genetic test that evaluates patients with early or intermediate AMD progressing to advanced choroidal neovascular disease within 2, 5, and 10 years. This test will help physicians tailor the management of their patients and your members. This could potentially lead to improved detection of wet AMD at an earlier stage, before much vision loss has occurred.
Premium Support Services for Physicians
Premium support services for ordering health care providers offered by Sequenom CMM include rapid turnaround time for test results, online ordering, clinical resources and billing assistance. If you wish to speak with someone in our Customer Service or Billing services, please contact us at 877-821-7266 or email us at info@SequenomCMM.com.
References
-
Palomaki GE, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13, as well as Down syndrome: An international collaborative study. Genet Med. 2012;14(3):296-305.
-
Canick JA, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn. 2012;32(8):730-734.
-
Mazloom AR, et al. Accuracy of Noninvasive Prenatal Sex Determination using Massively Parallel Sequencing in Samples from a Large Clinical Validation Study. Poster presented at the 2012 Annual American Society of Human Genetics Meeting, November 6-10, 2012; San Francisco, CA.
-
Sequenom Center for Molecular Medicine, unpublished data 2013.